These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK. Gallenmüller C; Müller-Felber W; Dusl M; Stucka R; Guergueltcheva V; Blaschek A; von der Hagen M; Huebner A; Müller JS; Lochmüller H; Abicht A Neuromuscul Disord; 2014 Jan; 24(1):31-5. PubMed ID: 24183479 [TBL] [Abstract][Full Text] [Related]
6. Congenital myasthenic syndromes and the formation of the neuromuscular junction. Beeson D; Webster R; Cossins J; Lashley D; Spearman H; Maxwell S; Slater CR; Newsom-Davis J; Palace J; Vincent A Ann N Y Acad Sci; 2008; 1132():99-103. PubMed ID: 18567858 [TBL] [Abstract][Full Text] [Related]
7. [Histochemical findings of and fine structural changes in motor endplates in diseases with neuromuscular transmission abnormalities]. Yoshimura T; Motomura M; Tsujihata M Brain Nerve; 2011 Jul; 63(7):719-27. PubMed ID: 21747142 [TBL] [Abstract][Full Text] [Related]
8. [Genetic defects and disorders at the neuromuscular junction]. Ohno K Brain Nerve; 2011 Jul; 63(7):669-78. PubMed ID: 21747136 [TBL] [Abstract][Full Text] [Related]
9. [Beneficial effects of 3,4-diaminopyridine in a 26-year-old woman with DOK7 congenital myasthenic syndrome who was originally diagnosed with facioscapulohumeral dystrophy]. Nishikawa A; Mori-Yoshimura M; Okamoto T; Oya Y; Nakata T; Ohno K; Murata M Rinsho Shinkeigaku; 2014; 54(7):561-4. PubMed ID: 25087557 [TBL] [Abstract][Full Text] [Related]
10. Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1. Finlayson S; Palace J; Belaya K; Walls TJ; Norwood F; Burke G; Holton JL; Pascual-Pascual SI; Cossins J; Beeson D J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1119-25. PubMed ID: 23447650 [TBL] [Abstract][Full Text] [Related]
11. Distinct phenotypes of congenital acetylcholine receptor deficiency. Burke G; Cossins J; Maxwell S; Robb S; Nicolle M; Vincent A; Newsom-Davis J; Palace J; Beeson D Neuromuscul Disord; 2004 Jun; 14(6):356-64. PubMed ID: 15145336 [TBL] [Abstract][Full Text] [Related]
12. [Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience]. Eymard B; Stojkovic T; Sternberg D; Richard P; Nicole S; Fournier E; Béhin A; Laforêt P; Servais L; Romero N; Fardeau M; Hantaï D; Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S45-55. PubMed ID: 23452772 [TBL] [Abstract][Full Text] [Related]
13. Congenital myasthenic syndrome with novel pathogenic variants in the COLQ gene associated with the presence of antibodies to acetylcholine receptors. Tay CG; Fong CY; Li L; Ganesan V; Teh CM; Gan CS; Thong MK J Clin Neurosci; 2020 Feb; 72():468-471. PubMed ID: 31831253 [TBL] [Abstract][Full Text] [Related]
14. Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up. Durmus H; Shen XM; Serdaroglu-Oflazer P; Kara B; Parman-Gulsen Y; Ozdemir C; Brengman J; Deymeer F; Engel AG Neuromuscul Disord; 2018 Apr; 28(4):315-322. PubMed ID: 29395675 [TBL] [Abstract][Full Text] [Related]
15. Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency. Sigoillot SM; Bourgeois F; Karmouch J; Molgó J; Dobbertin A; Chevalier C; Houlgatte R; Léger J; Legay C FASEB J; 2016 Jun; 30(6):2382-99. PubMed ID: 26993635 [TBL] [Abstract][Full Text] [Related]
16. Current status of the congenital myasthenic syndromes. Engel AG Neuromuscul Disord; 2012 Feb; 22(2):99-111. PubMed ID: 22104196 [TBL] [Abstract][Full Text] [Related]
17. Recurrent COLQ mutation in congenital myasthenic syndrome. Guven A; Demirci M; Anlar B Pediatr Neurol; 2012 Apr; 46(4):253-6. PubMed ID: 22490774 [TBL] [Abstract][Full Text] [Related]